Singh Enakshi 4
4 · Zymergen Inc. · Filed Dec 30, 2021
Insider Transaction Report
Form 4
Singh Enakshi
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2021-12-28$1.70/sh+50,000$85,000→ 227,000 total - Exercise/Conversion
Stock Options
2021-12-28−50,000→ 0 totalExercise: $1.70Exp: 2025-07-30→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The transaction by the Reporting Person is an exercise of an in-the-money option for cash consideration and does not involve the sale of any shares.
- [F2]The shares subject to the Option are fully vested and immediately exercisable.